메뉴 건너뛰기




Volumn 88, Issue 6, 2002, Pages 938-942

Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study

Author keywords

Anticoagulant therapy; Bleeding; Pulmonary embolism; Recurrences; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

EID: 12244289623     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613337     Document Type: Article
Times cited : (25)

References (28)
  • 2
    • 0024296238 scopus 로고
    • Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight?
    • Vitoux JF, Aiach M, Roncato M, Fiessinger JN. Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight? Thromb Haemost 1988; 59: 120.
    • (1988) Thromb Haemost , vol.59 , pp. 120
    • Vitoux, J.F.1    Aiach, M.2    Roncato, M.3    Fiessinger, J.N.4
  • 3
    • 0032144285 scopus 로고    scopus 로고
    • Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgery
    • Kovacs MJ, Weir K, MacKinnon K, Keeney M, Brien WF, Cruickshank MK. Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgery. Thromb Res 1998; 91: 137-42.
    • (1998) Thromb Res , vol.91 , pp. 137-142
    • Kovacs, M.J.1    Weir, K.2    MacKinnon, K.3    Keeney, M.4    Brien, W.F.5    Cruickshank, M.K.6
  • 4
    • 0031755859 scopus 로고    scopus 로고
    • Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis
    • Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK for the Certoparin Study Group. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Int Angiol 1998; 17: 135-45.
    • (1998) Int Angiol , vol.17 , pp. 135-145
    • Kirchmaier, C.M.1    Wolf, H.2    Schäfer, H.3    Ehlers, B.4    Breddin, H.K.5
  • 5
    • 0033926129 scopus 로고    scopus 로고
    • The effect of body weight on dalteparin pharmacokinetics. A preliminary study
    • Yee JY, Duffull SB. The effect of body weight on dalteparin pharmacokinetics. A preliminary study. Eur J Clin Pharmacol 2000; 56: 293-7.
    • (2000) Eur J Clin Pharmacol , vol.56 , pp. 293-297
    • Yee, J.Y.1    Duffull, S.B.2
  • 6
    • 0034020857 scopus 로고    scopus 로고
    • Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN investigators
    • Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN investigators. Thromb Haemost 2000; 83: 652-6.
    • (2000) Thromb Haemost , vol.83 , pp. 652-656
    • Harenberg, J.1    Schmidt, J.A.2    Koppenhagen, K.3    Tolle, A.4    Huisman, M.V.5    Büller, H.R.6
  • 8
    • 0034776652 scopus 로고    scopus 로고
    • Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low molecular weight heparin certoparin
    • Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low molecular weight heparin certoparin. Semin Thromb Haemost 2001; 27: 513-8.
    • (2001) Semin Thromb Haemost , vol.27 , pp. 513-518
    • Harenberg, J.1    Huisman, M.V.2    Tolle, A.R.3    Breddin, H.K.4    Kirchmaier, C.M.5
  • 9
    • 0032507023 scopus 로고    scopus 로고
    • Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    • Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-62.
    • (1998) JAMA , vol.279 , pp. 458-462
    • Douketis, J.D.1    Kearon, C.2    Bates, S.3    Duku, E.K.4    Ginsberg, J.S.5
  • 10
    • 0034639245 scopus 로고    scopus 로고
    • Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
    • Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160: 3431-6.
    • (2000) Arch Intern Med , vol.160 , pp. 3431-3436
    • Douketis, J.D.1    Foster, G.A.2    Crowther, M.A.3    Prins, M.H.4    Ginsberg, J.S.5
  • 13
    • 0028109313 scopus 로고
    • Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism. A prospective study
    • Monreal M, Lafoz E, Ruíz J, Callejas JM, Arias A. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism. A prospective study. Eur J Vasc Surg 1994; 8: 584-9.
    • (1994) Eur J Vasc Surg , vol.8 , pp. 584-589
    • Monreal, M.1    Lafoz, E.2    Ruíz, J.3    Callejas, J.M.4    Arias, A.5
  • 14
    • 0030927897 scopus 로고    scopus 로고
    • Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy
    • Monreal M, Urrutia A, Martí S, Cuxart A, Roncales J. Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy. Haemostasis 1997; 27: 91-8.
    • (1997) Haemostasis , vol.27 , pp. 91-98
    • Monreal, M.1    Urrutia, A.2    Martí, S.3    Cuxart, A.4    Roncales, J.5
  • 15
    • 0024383599 scopus 로고
    • Real-time ultrasound for diagnosis of symptomatic venous thrombosis and for screening of patients at risk: Correlation with ascending conventional venography
    • Monreal M, Montserrat E, Salvador R, Bechini J, Donoso L, Callejas JM, Foz M. Real-time ultrasound for diagnosis of symptomatic venous thrombosis and for screening of patients at risk: Correlation with ascending conventional venography. Angiology 1989; 40: 527-33.
    • (1989) Angiology , vol.40 , pp. 527-533
    • Monreal, M.1    Montserrat, E.2    Salvador, R.3    Bechini, J.4    Donoso, L.5    Callejas, J.M.6    Foz, M.7
  • 17
    • 0023275245 scopus 로고
    • Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis
    • Doyle J, Turpie AJ, Hirsh J, Best C, Kinch D, Levine MN, Gent M. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. Ann Intern Med 1987; 107: 441-5.
    • (1987) Ann Intern Med , vol.107 , pp. 441-445
    • Doyle, J.1    Turpie, A.J.2    Hirsh, J.3    Best, C.4    Kinch, D.5    Levine, M.N.6    Gent, M.7
  • 18
    • 0030990740 scopus 로고    scopus 로고
    • Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: Rationale and clinical results
    • Crowther M, Hirsh J. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: Rationale and clinical results. Semin Thromb Haemost 1997; 23: 77-81.
    • (1997) Semin Thromb Haemost , vol.23 , pp. 77-81
    • Crowther, M.1    Hirsh, J.2
  • 19
    • 0032907090 scopus 로고    scopus 로고
    • Deep venous thrombosis: Outpatient management is now FDA approved
    • Baron RM, Goldhaber SZ. Deep venous thrombosis: Outpatient management is now FDA approved. J Thromb Thrombolysis 1999; 7: 133-22.
    • (1999) J Thromb Thrombolysis , vol.7 , pp. 113-122
    • Baron, R.M.1    Goldhaber, S.Z.2
  • 20
    • 0033039125 scopus 로고    scopus 로고
    • Which DVT patients could be considered the best candidates for home therapy?
    • Monreal M. Which DVT patients could be considered the best candidates for home therapy? Thromb Haemost 1999; 81: 996-7.
    • (1999) Thromb Haemost , vol.81 , pp. 996-997
    • Monreal, M.1
  • 22
    • 0028054767 scopus 로고
    • Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis
    • Moser KM, Fedullo PF, Litte John JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-225.
    • (1994) JAMA , vol.271 , pp. 223-225
    • Moser, K.M.1    Fedullo, P.F.2    Litte John, J.K.3    Crawford, R.4
  • 24
    • 0024556965 scopus 로고
    • Asymptomatic pulmonary embolism in patients with deep vein thrombosis. Is it useful to take a lung scan to rule out this condition?
    • Monreal M, Rey-Joly C, Ruíz J, Salvador R, Lafoz E, Viver E. Asymptomatic pulmonary embolism in patients with deep vein thrombosis. Is it useful to take a lung scan to rule out this condition? J Cardiovasc Surg 1989; 30: 104-7.
    • (1989) J Cardiovasc Surg , vol.30 , pp. 104-107
    • Monreal, M.1    Rey-Joly, C.2    Ruíz, J.3    Salvador, R.4    Lafoz, E.5    Viver, E.6
  • 25
    • 0025959753 scopus 로고
    • Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study
    • Monreal M, Lafoz E, Ruíz J, Valls R, Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 1991; 99: 280-3.
    • (1991) Chest , vol.99 , pp. 280-283
    • Monreal, M.1    Lafoz, E.2    Ruíz, J.3    Valls, R.4    Alastrue, A.5
  • 26
    • 0028030577 scopus 로고
    • Pulmonary embolism in patients with upper extremity DVT associated to venous central lines. A prospective study
    • Monreal M, Raventos A, Lerma R, Ruíz J, Lafoz E, Alastrue A, Llamazares JF. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines. A prospective study. Thromb Haemost 1994; 72: 548-50.
    • (1994) Thromb Haemost , vol.72 , pp. 548-550
    • Monreal, M.1    Raventos, A.2    Lerma, R.3    Ruíz, J.4    Lafoz, E.5    Alastrue, A.6    Llamazares, J.F.7
  • 27
    • 0035010422 scopus 로고    scopus 로고
    • Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs
    • Monreal M, Ruíz J, Fraile M, Bonet M, Davant E, Muchart J, Vallejos V. Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs. Thromb Haemost 2001; 85: 771-4.
    • (2001) Thromb Haemost , vol.85 , pp. 771-774
    • Monreal, M.1    Ruíz, J.2    Fraile, M.3    Bonet, M.4    Davant, E.5    Muchart, J.6    Vallejos, V.7
  • 28
    • 0028785452 scopus 로고
    • Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
    • Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995; 108 (Suppl): 258S-75S.
    • (1995) Chest , vol.108 , Issue.SUPPL.
    • Hirsh, J.1    Raschke, R.2    Warkentin, T.E.3    Dalen, J.E.4    Deykin, D.5    Poller, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.